Roderick C. Van Den Bergh

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 245 publications

"I think that there is a lack of information and awareness": A PRAISE-U Clinical Trial Update.

"I think that there is a lack of information and awareness": A PRAISE-U Clinical Trial Update.

Journal: European urology focus

Published: July 17, 2026

The Prognostic Value of Baseline PSA Density on Long-term Oncological Outcomes in Men with an Initial Negative Prostate Biopsy: Results from ERSPC Rotterdam.

The Prognostic Value of Baseline PSA Density on Long-term Oncological Outcomes in Men with an Initial Negative Prostate Biopsy: Results from ERSPC Rotterdam.

Journal: European urology open science

Published: June 10, 2026

PROTEUS Trial the Day After: Practice Changing or Premature Escalation?

PROTEUS Trial the Day After: Practice Changing or Premature Escalation?

Journal: European urology oncology

Published: June 03, 2026

Screening for prostate cancer; a screening program is favored over current opportunistic testing

Screening for prostate cancer; a screening program is favored over current opportunistic testing

Journal: Nederlands tijdschrift voor geneeskunde

Published: June 02, 2026

Incorporating Lower Urinary Tract Symptoms to Predict the Risk of Positive Prostate Magnetic Resonance Imaging.

Incorporating Lower Urinary Tract Symptoms to Predict the Risk of Positive Prostate Magnetic Resonance Imaging.

Journal: European urology open science

Published: May 10, 2026

What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.

What Comes After Matters: The Importance of Postprogression Care in Patients with Metastatic Hormone-sensitive Prostate Cancer.

Journal: European urology

Published: May 07, 2026

Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancer.

Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancer.

Journal: BJU international

Published: April 20, 2026

Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)-Prospective Multicentre Cohort Study Protocol.

Sequential Imaging of Suspicion of Prostate Cancer: Reducing Overdiagnosis and Unnecessary Biopsy with Timely Diagnosis of Significant Cancer (SPROUT)-Prospective Multicentre Cohort Study Protocol.

Journal: European urology oncology

Published: April 16, 2026

Who, When, and How: Watchful Waiting in the ERSPC Rotterdam.

Who, When, and How: Watchful Waiting in the ERSPC Rotterdam.

Journal: European urology open science

Published: March 12, 2026

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

Journal: European urology

Published: March 05, 2026

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

Journal: European urology

Published: March 05, 2026

Evaluation of the Patient Acceptability of Automated Communication of Prostate-specific Antigen Results After Local Treatment for Prostate Cancer.

Evaluation of the Patient Acceptability of Automated Communication of Prostate-specific Antigen Results After Local Treatment for Prostate Cancer.

Journal: European urology open science

Published: March 01, 2026

Showing 1-12 of 245

Last Updated: 09/26/2026